Edoceo Devices is an emerging med-tech & biotech American company with Exclusive and Groundbreaking Biosensor Technology that could Help in the fight against COVID-19 – as well as Future Viral and Bacterial Threats to our normal family way of life. The priority is finalizing the development and marketing of this technology to produce two on-site proprietary detection biosensors - with the goal of providing essential rapid early warning to the presence of harmful pathogens: • Edoceo B-DetectTM - A portable virulent bacterial Testing device • Edoceo V-DetectTM - A portable virus biosensing device Edoceo B-Detect and V-Detect have the potential to change the world of rapid, portable, affordable, and accurate testing for pathogens including virulent bacteria and the presence of a range of viruses. These innovative detection platforms are being developed for the aquaculture, veterinary, health care, food processing and home monitoring markets, amongst others – Edoceo detection devices are based on the work of their Chief Science Officer, the Multi-Award-Winning Dr. Kenneth Reardon, in collaboration with many years of study and research by the scientists at Colorado State University that is exclusively licensed to Edoceo. *Breaking News* As a potential bonus to investors, and having secured substantial access to supplies, Edoceo Devices are commencing commercialization of a rapid (< 17 minutes), simple, saliva-based antigen test for the Coronavirus – Edoceo A-Detect which is already CE marked for distribution in the European Union and we are also planning a US FDA Emergency Use Application for distribution and sales in the United States.